Matthew Davidson

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.

Get AZR alerts

About Matthew Davidson

Matthew Davidson is recorded as CEO at Azora Therapeutics, Inc. (DE) (AZR) since August 13, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed August 13, 2026 that Matthew Davidson was appointed President and Chief Executive Officer. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO), Kevin Schuyler (Chairman) and 7 others.

“Matthew Davidson, the Company's Chief Development Officer and a member of our Board of Directors, will be appointed as the Company's President and Chief Executive Office”

Azora Therapeutics, Inc. (DE) Form 8-K, filed August 13, 2026 · Read the filing

Affiliation history

Azora Therapeutics, Inc. (DE) (AZR)
CEO

SEC 8-K

Current
2026-08-13–present

Company network

Azora Therapeutics, Inc. (DE)

AZR

Current role

Biotechnology · Healthcare

CEO

2026-08-13–present

Leadership on record at Azora Therapeutics, Inc. (DE)

Matthew Davidson, Ph.D. CEO
William B. Stilley CEO
Kevin Schuyler Chairman
Celia Economides CFO
Vinay K. Shah CFO
Cary Claiborne COO, Board Member
Cary J. Claiborne COO, Board Member
Tony Goodman COO
Dr. Jack Reich Board Member
Matt Davidson Board Member

Recent activity

Executive change Appointed: President and Chief Executive Officer Azora Therapeutics, Inc. (DE) (AZR)
2026-08-13